Doctor first, always
Every program begins with a licensed medical provider reviewing your intake. No treatment is dispensed without physician approval.
About ZYNDIO
A physician-led telehealth platform connecting patients with licensed medical providers. Treatment is dispensed by U.S.-licensed pharmacies only after clinical approval.
Educational, not therapeutic claimsU.S.-licensed pharmaciesPhysician approval required
About
Who We Are
Who we are, how we operate, and the people accountable for the experience.
Contact: support@zyndio.com
Mission
ZYNDIO is a physician-led telehealth platform currently focused on GLP-1 weight loss care for eligible adults. Every program begins with a clinical intake — a licensed medical provider reviews your case before any treatment is approved.
We do not make therapeutic, diagnostic, or curative claims. Prescribing decisions are made by independent licensed medical providers, and prescriptions are dispensed only by U.S.-licensed pharmacies. No treatment is provided without physician approval.
U.S.-licensed pharmacies
Prescriptions are fulfilled exclusively by U.S.-licensed pharmacies. Compounded medications may be used when clinically appropriate.
Private, continuous care
Discreet delivery, simple refills, and continuity with your care team — not a one-and-done transaction. Subject to provider availability and state regulations.
Founder
Brett Hudson — Founder. Brett leads product, partnerships, and the overall member experience.
For founder-related inquiries, email support@zyndio.com.
ZYNDIO's scientific partner: Professor Jin-Xiong She, PhD
Founder & CEO, Jinfiniti Precision Medicine
500+
peer-reviewed publications
22,000+
scientific citations
$100M+
competitive research funding
424,000+
newborns screened in landmark research
First
commercial intracellular NAD+ test
2018
founded Jinfiniti Precision Medicine
Dr. She earned his PhD in molecular genetics at the University of Montpellier in France. He advanced quickly through the University of Florida, from Assistant Professor to Full and Endowed Professor. In 2002 the Georgia Research Alliance named him Eminent Scholar in Genomic Medicine at the Medical College of Georgia. There he founded and directed the Center for Biotechnology and Genomic Medicine and led landmark international research on the early-life origins of autoimmune disease.
Today he leads Jinfiniti Precision Medicine in Augusta, Georgia. The company runs its own high-complexity CLIA laboratory. It pioneered the first commercial intracellular NAD+ test and builds precision nutritional formulas guided by measured biology. His full story is on the Jinfiniti site.
What this brings to ZYNDIO members
- Advanced cellular biomarker science, including NAD+, Klotho and cellular-senescence testing, is planned to flow into the ZYNDIO clinical workflow through authorized data integrations.
- Precision nutritional formulas developed by Dr. She's team are planned to become available under the ZYNDIO label. The lineup starts with NAD+ support, creatine, prebiotics, collagen and protein shakes.
- An approach grounded in measured biology instead of guesswork, with his planned involvement extending to the ZYNDIO board of directors.
Dr. She's philosophy in 75 seconds: Test. Act. Optimize.
Operations & Compliance
U.S.-licensed pharmacies
Prescriptions are dispensed by U.S.-licensed pharmacies. Compounded preparations are prepared by licensed compounding pharmacies when clinically appropriate; compounded medications are not FDA-approved drug products.
Licensed medical provider review
Every program is reviewed by an independent licensed medical provider authorized for your state. The provider evaluates eligibility, contraindications, and clinical appropriateness — and only issues a prescription when treatment is medically appropriate. No prescription is written without provider approval.
Clinical privacy and security controls
Account, intake, and treatment-related data is routed through approved clinical and support systems where applicable, with encryption in transit and at rest, role-scoped access, and audit logging on regulated workflows.
LegitScript status
ZYNDIO links to LegitScript status verification so approval details can be checked against the current public record.
State availability varies. See state legality for the current map and the states where a live video visit with a doctor is required.
Contact
ZYNDIO
Customer support hours
Monday–Friday, 9 AM – 6 PM EST
Responses typically within 2–4 business days
(excluding weekends + holidays)
Support Number: (307) 227 9322
Support Email: care@zyndio.com
Mailing address
Zyndio, LLC30 N Gould St Ste RSheridan, WY 82801USA